Holdings of Health Sciences Portfolio
PACIFIC SELECT FUND ·133 declared positions · as of Mar 31, 2026
Original filing · Net assets 356.8M $ · Ten largest lines: 50.4 % of the equity sleeve
Sector breakdown
- Health care 81.2 %
- Materials 0.6 %
- Technology 0.3 %
- Consumer discretionary 0.3 %
- Industrials 0.2 %
- Unattributed 17.3 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 97.5 %
- GBP 1.3 %
- CHF 0.6 %
- EUR 0.3 %
- JPY 0.2 %
- DKK 0.1 %
The quoted currency of each line, as declared.
Country breakdown
- US 93.5 %
- IL 1.8 %
- NL 1.5 %
- GB 1.3 %
- CH 0.7 %
- BE 0.3 %
- BM 0.2 %
- JP 0.2 %
- CA 0.1 %
- JE 0.1 %
- DK 0.1 %
- DE 0.1 %
- Other countries 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 116 | 325.7M $ | 93.46 % |
| 2 | IL | 1 | 6.2M $ | 1.79 % |
| 3 | NL | 1 | 5.4M $ | 1.54 % |
| 4 | GB | 2 | 4.5M $ | 1.29 % |
| 5 | CH | 2 | 2.5M $ | 0.72 % |
| 6 | BE | 2 | 1M $ | 0.29 % |
| 7 | BM | 1 | 787.8K $ | 0.23 % |
| 8 | JP | 1 | 749.6K $ | 0.22 % |
| 9 | CA | 1 | 413.2K $ | 0.12 % |
| 10 | JE | 1 | 374.9K $ | 0.11 % |
| 11 | DK | 1 | 230.5K $ | 0.07 % |
| 12 | DE | 1 | 226.1K $ | 0.06 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 159,722 | 39M $ | 10.94 % |
| 2 | Eli Lilly & Co | 40,025 | 36.8M $ | 10.32 % |
| 3 | Merck & Co Inc | 157,711 | 19M $ | 5.32 % |
| 4 | AbbVie Inc | 68,882 | 15M $ | 4.20 % |
| 5 | Gilead Sciences Inc | 102,982 | 14.4M $ | 4.02 % |
| 6 | Amgen Inc | 35,170 | 12.4M $ | 3.47 % |
| 7 | UnitedHealth Group Inc | 40,166 | 10.9M $ | 3.05 % |
| 8 | Pfizer Inc | 350,127 | 9.8M $ | 2.76 % |
| 9 | Vertex Pharmaceuticals Inc | 21,484 | 9.6M $ | 2.69 % |
| 10 | Intuitive Surgical Inc | 19,070 | 8.8M $ | 2.46 % |
| 11 | Abbott Laboratories | 81,496 | 8.4M $ | 2.35 % |
| 12 | Edwards Lifesciences Corp | 102,345 | 8.2M $ | 2.30 % |
| 13 | Danaher Corp | 36,464 | 6.9M $ | 1.94 % |
| 14 | Thermo Fisher Scientific Inc | 12,830 | 6.3M $ | 1.77 % |
| 15 | Teva Pharmaceutical Industries Ltd | 207,331 | 6.2M $ | 1.75 % |
| 16 | Boston Scientific Corp | 89,153 | 5.6M $ | 1.57 % |
| 17 | Argenx SE | 7,332 | 5.4M $ | 1.50 % |
| 18 | Stryker Corp | 15,877 | 5.2M $ | 1.46 % |
| 19 | Medtronic PLC | 51,959 | 4.5M $ | 1.26 % |
| 20 | AstraZeneca PLC | 22,914 | 4.5M $ | 1.26 % |
| 21 | Regeneron Pharmaceuticals, Inc. | 5,239 | 4M $ | 1.13 % |
| 22 | Biogen Inc | 21,727 | 4M $ | 1.12 % |
| 23 | Bristol-Myers Squibb Co | 65,657 | 4M $ | 1.12 % |
| 24 | Insmed Inc | 23,274 | 3.8M $ | 1.07 % |
| 25 | HCA Healthcare Inc | 7,531 | 3.6M $ | 1.00 % |
| 26 | Cencora Inc | 10,756 | 3.4M $ | 0.95 % |
| 27 | Rhythm Pharmaceuticals Inc | 32,248 | 2.8M $ | 0.79 % |
| 28 | Penumbra Inc | 7,995 | 2.6M $ | 0.74 % |
| 29 | IDEXX Laboratories Inc | 4,616 | 2.6M $ | 0.73 % |
| 30 | Dexcom Inc | 39,665 | 2.5M $ | 0.70 % |
| 31 | Guardant Health Inc | 26,786 | 2.5M $ | 0.69 % |
| 32 | Protagonist Therapeutics Inc | 22,226 | 2.3M $ | 0.66 % |
| 33 | Medline Inc | 51,583 | 2.3M $ | 0.64 % |
| 34 | Novartis AG | 14,858 | 2.3M $ | 0.64 % |
| 35 | Waters Corp | 7,514 | 2.2M $ | 0.63 % |
| 36 | Incyte Corp | 23,632 | 2.2M $ | 0.62 % |
| 37 | Galderma Group AG | 11,157 | 2.2M $ | 0.61 % |
| 38 | Nuvalent Inc | 19,497 | 2M $ | 0.56 % |
| 39 | United Therapeutics Corp | 3,301 | 2M $ | 0.55 % |
| 40 | Cogent Biosciences Inc | 49,523 | 1.9M $ | 0.53 % |
| 41 | Alnylam Pharmaceuticals Inc | 5,633 | 1.9M $ | 0.52 % |
| 42 | Agilent Technologies Inc | 16,087 | 1.8M $ | 0.51 % |
| 43 | Revolution Medicines Inc | 18,010 | 1.8M $ | 0.49 % |
| 44 | McKesson Corp | 2,010 | 1.7M $ | 0.49 % |
| 45 | Moderna Inc | 33,405 | 1.7M $ | 0.48 % |
| 46 | Natera Inc | 8,143 | 1.6M $ | 0.46 % |
| 47 | CVS Health Corp | 21,978 | 1.6M $ | 0.44 % |
| 48 | Elevance Health Inc | 5,311 | 1.6M $ | 0.44 % |
| 49 | IQVIA Holdings Inc | 8,371 | 1.4M $ | 0.40 % |
| 50 | Cooper Cos Inc/The | 18,422 | 1.3M $ | 0.37 % |
| 51 | Terns Pharmaceuticals Inc | 22,202 | 1.2M $ | 0.33 % |
| 52 | Illumina Inc | 9,156 | 1.1M $ | 0.32 % |
| 53 | BioMarin Pharmaceutical Inc | 19,970 | 1.1M $ | 0.32 % |
| 54 | Bruker Corp | 29,925 | 1.1M $ | 0.30 % |
| 55 | Veeva Systems Inc | 6,034 | 1.1M $ | 0.30 % |
| 56 | Summit Therapeutics Inc | 54,464 | 1M $ | 0.29 % |
| 57 | Apogee Therapeutics Inc | 12,138 | 1M $ | 0.29 % |
| 58 | Quest Diagnostics Inc | 5,093 | 998.1K $ | 0.28 % |
| 59 | UCB SA | 3,202 | 964.8K $ | 0.27 % |
| 60 | Dianthus Therapeutics Inc | 11,071 | 929.1K $ | 0.26 % |
| 61 | Bridgebio Pharma Inc | 12,436 | 923.5K $ | 0.26 % |
| 62 | Stoke Therapeutics Inc | 28,316 | 922K $ | 0.26 % |
| 63 | West Pharmaceutical Services Inc | 3,617 | 906.6K $ | 0.25 % |
| 64 | STERIS PLC | 4,051 | 895.8K $ | 0.25 % |
| 65 | LB Pharmaceuticals Inc | 33,445 | 824.8K $ | 0.23 % |
| 66 | Viking Therapeutics Inc | 25,077 | 816K $ | 0.23 % |
| 67 | Humana Inc | 4,672 | 810.1K $ | 0.23 % |
| 68 | Roivant Sciences Ltd | 28,440 | 787.8K $ | 0.22 % |
| 69 | Ionis Pharmaceuticals Inc | 10,319 | 774.9K $ | 0.22 % |
| 70 | Daiichi Sankyo Co Ltd | 41,900 | 749.6K $ | 0.21 % |
| 71 | Cytokinetics Inc | 10,952 | 721.8K $ | 0.20 % |
| 72 | Erasca Inc | 42,899 | 694.1K $ | 0.19 % |
| 73 | Agios Pharmaceuticals Inc | 20,492 | 693.2K $ | 0.19 % |
| 74 | Elanco Animal Health Inc | 28,619 | 684.9K $ | 0.19 % |
| 75 | Scholar Rock Holding Corp | 13,630 | 670.1K $ | 0.19 % |
| 76 | Hologic Inc | 8,399 | 634.9K $ | 0.18 % |
| 77 | Arcellx Inc | 5,502 | 631.7K $ | 0.18 % |
| 78 | Neurocrine Biosciences Inc | 4,679 | 616.4K $ | 0.17 % |
| 79 | Bio-Techne Corp | 11,772 | 615.2K $ | 0.17 % |
| 80 | Viridian Therapeutics Inc | 31,305 | 612.3K $ | 0.17 % |
| 81 | Exelixis Inc | 13,864 | 594.6K $ | 0.17 % |
| 82 | MBX Biosciences Inc | 19,741 | 589.3K $ | 0.17 % |
| 83 | Charles River Laboratories International Inc | 3,410 | 588.2K $ | 0.16 % |
| 84 | Arcus Biosciences Inc | 27,126 | 585.9K $ | 0.16 % |
| 85 | Glaukos Corp | 5,290 | 569.5K $ | 0.16 % |
| 86 | Oruka Therapeutics Inc | 11,025 | 540.8K $ | 0.15 % |
| 87 | Edgewise Therapeutics Inc | 15,344 | 483.3K $ | 0.14 % |
| 88 | Eikon Therapeutics Inc | 43,100 | 456K $ | 0.13 % |
| 89 | Bright Minds Biosciences Inc | 5,663 | 413.2K $ | 0.12 % |
| 90 | Intellia Therapeutics Inc | 31,327 | 401.6K $ | 0.11 % |
| 91 | Kodiak Sciences Inc | 10,125 | 386K $ | 0.11 % |
| 92 | Alumis Inc | 17,411 | 383.6K $ | 0.11 % |
| 93 | Immunome Inc | 17,186 | 375.9K $ | 0.11 % |
| 94 | Novocure Ltd | 34,399 | 374.9K $ | 0.11 % |
| 95 | Palvella Therapeutics Inc | 3,008 | 374.9K $ | 0.11 % |
| 96 | Enanta Pharmaceuticals Inc | 29,263 | 369.6K $ | 0.10 % |
| 97 | BridgeBio Oncology Therapeutics Inc | 40,663 | 363.9K $ | 0.10 % |
| 98 | RadNet Inc | 6,429 | 359.3K $ | 0.10 % |
| 99 | Mettler-Toledo International Inc | 276 | 348.1K $ | 0.10 % |
| 100 | Immunocore Holdings PLC | 11,435 | 344.8K $ | 0.10 % |